NCT06999785View on ClinicalTrials.gov

Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

November 15, 2027

Conditions
Hyperbaric OxygenGenotoxicityMalignancy
Interventions
BIOLOGICAL

Blood test

a blood test before and after the first oxygen therapy session, as well as after the last session

Trial Locations (1)

Unknown

CHU Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT06999785 - Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage | Biotech Hunter | Biotech Hunter